Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations-Reference-Cited by-同舟云学术

Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations

Published:2021-09-27 Issue: Volume: Page:1-14
ISSN:2047-7724
Container-title:Pathogens and Global Health
language:en
Short-container-title:Pathogens and Global Health

Author:

Martinón-Torres Federico¹^ORCID,Taha Muhamed-Kheir²^ORCID,Knuf Markus³,Abbing-Karahagopian Victoria⁴^ORCID,Pellegrini Michele⁵^ORCID,Bekkat-Berkani Rafik⁶^ORCID,Abitbol Véronique⁷^ORCID

Affiliation:

1. Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP, Instituto De Investigación Sanitaria De Santiago and Universidad De Santiago De Compostela (Usc), Santiago de Compostela, Galicia, Spain

2. Institut Pasteur, Invasive Bacterial Infections Unit, National Reference Centre for Meningococci and Haemophilus Influenza, Paris, France

3. Klinik Für Kinder- Und Jugendmedizin, Worms, Germany and Pediatric Infectious Diseases, University Medicine, Mainz, Germany

4. GSK, Amsterdam, The Netherlands

5. GSK, Siena, Italy

6. GSK, Rockville, MD, United States

7. GSK, Rueil-Malmaison, France

Funder

GlaxoSmithKline Biologicals SA

Publisher

Informa UK Limited

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine,Microbiology,Parasitology